Location: Palo Alto, CA
CIK: 0001668343 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $113M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Rocket Lab USA, Inc. | 3,388,249 | $86.3M | 76.4% | $5.53 | — | COM | 773122106 |
| RXRX | Recursion Pharmaceuticals, Inc. | 3,951,141 | $26.71M | 23.6% | $18.82 | -64.3% | CL A | 75629V104 |